Serotonin syndrome associated with clozapine withdrawal

JAMA Neurology

Volumn 70, Issue 8, 2013, Pages 1054-1055

  Stevenson, Elizabeth ^a   Schembri, Frank ^a   Green, Deborah M ^b   Burns, Joseph D ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CITALOPRAM; CLOZAPINE; CYPROHEPTADINE; METOCLOPRAMIDE; ONDANSETRON; PROMETHAZINE;

ADULT; AGITATION; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; CLONUS; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG SAFETY; EPILEPTIC DISCHARGE; FEMALE; GASTROINTESTINAL SYMPTOM; HAND PAIN; HUMAN; HYPERREFLEXIA; HYPERSALIVATION; INTRAVENOUS ADMINISTRATION; LEG PAIN; LOADING DRUG DOSE; NAUSEA AND VOMITING; PRIORITY JOURNAL; SCHIZOPHRENIA; SEROTONIN SYNDROME; VIRAL GASTROENTERITIS;

EID: 84882332464     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.95     Document Type: Article

References (12)

1. Shiovitz TM,Welke TL, Tigel PD, et al. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull. 1996;22(4):591-595.
2. Tollefson GD, DellvaMA, Mattler CA, Kane JM, Wirshing DA, Kinon BJ; The Collaborative Crossover Study Group. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. J Clin Psychopharmacol. 1999;19(5):435-443.
3. Goudie AJ. What is the clinical significance of the discontinuation syndrome seen with clozapine? J Psychopharmacol. 2000;14(2):188-192.
4. Ahmed S, Chengappa KN, Naidu VR, Baker RW, Parepally H, Schooler NR. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series. J Clin Psychiatry. 1998;59(9):472-477.
5. Zerjav-Lacombe S, Dewan V. Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine. Ann Pharmacother. 2001;35(2):180-182.
6. Zesiewicz TA, Borra S, Hauser RA. Clozapine withdrawal symptoms in a Parkinson's disease patient. Mov Disord. 2002;17(6):1365-1367.
7. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.
8. PytliakM, Vargová V, Mechírová V, Felšöci M. Serotonin receptors-from molecular biology to clinical applications. Physiol Res. 2011;60(1):15-25.
9. Matsubara S, Meltzer HY. Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex. Life Sci. 1989;45(15):1397-1406.
10. Huang XF, Tan YY, Huang X,Wang Q. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain. Neurosci Res. 2007;59(3):314-321.
11. Fisher AA, DavisMW. Serotonin syndrome caused by selective serotonin reuptake-inhibitors -metoclopramide interaction. Ann Pharmacother. 2002;36(1):67-71.
12. Lappin RI, Auchincloss EL. Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med. 1994;331(15):1021-1022.